Keyphrases
Glycogen Synthase Kinase 3 (GSK3)
100%
Human Neural Stem Cells (hNSCs)
85%
Intestinal Disorders
85%
Experimental Cerebral Ischemia
85%
Angong Niuhuang Wan
85%
Facet-dependent Activity
85%
Protective Effect
85%
Redox Homeostasis
85%
Bioreactor
85%
Cerebral Ischemia Injury
85%
Wound Healing
85%
Neural Stem Cells
85%
Non-pathogenic
85%
Heme oxygenase-1 (HO-1)
85%
Meta-analysis
85%
Scale-up Production
85%
Acinetobacter Calcoaceticus
85%
Parkinson's Disease
85%
Rhamnolipid
85%
Systematic Meta-analysis
85%
Alzheimer's Disease
85%
Confidence Interval
85%
Odds Ratio
49%
CAT-like
42%
Cerebral Ischemia
38%
Neuronal Differentiation
28%
Octahedron
28%
Transforming Growth factor-β1 (TGF-β1)
25%
Neurodegenerative Diseases
21%
Infarct Area
19%
L929 Fibroblasts
17%
Calcoaceticus
17%
Helicobacter Pylori (H. pylori)
14%
(100) Facets
14%
Facet-dependent
14%
ReNcell VM
14%
(111) Facet
14%
Mimetic Activity
14%
Progenitor Cell Therapy
14%
Differentiation Rate
14%
Biological Processes
14%
Differentiation of Self
14%
High Survival
14%
Oxidative Stress
14%
Surface Chemistry
14%
Self-renewal
14%
Electron Density
14%
Stress-induced
14%
Reactive Oxygen Species Production
14%
Cerium Oxide
14%
CeO2 Nanoparticles
14%
Therapeutic Strategies
14%
Irritable Bowel Syndrome
14%
Inflammatory Bowel Disease
14%
Survival Rate
14%
Active Sites
14%
Multi-enzyme
14%
Mechanistic Studies
14%
Reactive Oxygen Species
14%
Apoptosis
14%
Catenin
14%
Intracellular Redox State
14%
Crystal Facet
14%
Hydrogen Peroxide
14%
Cerebral Dysfunction
9%
Cerebral Ischemia-reperfusion
9%
Brain Oxidative Stress
9%
Functional Score
9%
Ischemic Damage
9%
Neurological Function
9%
Nissl
9%
Traditional Chinese Medicine
9%
Sprague-Dawley Rats
9%
Neurological Deficit Score
9%
Target-based Approach
9%
Transient Middle Cerebral Artery Occlusion (tMCAO)
9%
Cerebral Infarct
9%
NeuN
9%
Oxidative Stress Status
9%
TUNEL
9%
Neuronal Apoptosis
9%
Antioxidant Properties
9%
Disease Prevention
9%
Phenotypic Approach
9%
Dose Effect
9%
Pretreatment Effect
9%
Opportunistic Pathogens
8%
Rhamnolipid Congeners
8%
Wound Healing Materials
8%
Contractile Proteins
8%
Wound Healing Property
8%
Wound Treatment
8%
Fibroblast Migration
8%
Excision Wound
8%
Di-rhamnolipids
8%
No Toxicity
8%
Cutaneous Wound
8%
Pseudomonas Aeruginosa (P. aeruginosa)
8%
Vehicle Control
8%
Batch Fermentation
8%
Protein Level
8%
Topical Application
8%
α-smooth muscle Actin (α-SMA)
8%
Smad3
8%
Mass Spectrometry
8%
Production Application
8%
Wound Healing Activity
8%
L929 Cells
8%
Biomedical Applications
8%
Purification Process
8%
Fourier Transform Infrared Spectroscopy (FT-IR)
8%
Smad3 Phosphorylation
8%
Intestinal Infection
7%
Intestinal Condition
7%
Intestinal Microbes
7%
Global Occurrence
7%
Health Plans
7%
Risk Estimation
7%
National Government
7%
Intestinal Bacterial
7%
Intestinal Health
7%
Helicobacter Pylori Infection
7%
Bacterial Infection
7%
Random Effects Model
7%
Fixed Effects Model
7%
Constipation
7%
PubMed
7%
Neurological Disorders
7%
Small Intestinal Bacterial Overgrowth
7%
Alzheimer's Disease Patient
7%
Diarrhea
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Calcoaceticus
85%
Reactive Oxygen Metabolite
85%
Parkinson's Disease
85%
Rhamnolipid
85%
Wound Healing
85%
Nanozymes
85%
Enteropathy
85%
Alzheimer's Disease
85%
Hydrogen Peroxide
42%
Degenerative Disease
42%
Survival Rate
42%
Cerium Oxide Nanoparticle
42%
Cerium Oxide
42%
Glycogen Synthase Kinase
42%
Catenin
42%
Helicobacter Pylori
28%
Transforming Growth Factor Beta1
23%
Irritable Colon
19%
Inflammatory Bowel Disease
19%
Wound
15%
Constipation
9%
Bacterial Infection
9%
Random Effects Model
9%
Intestine Infection
9%
Diarrhea
9%
Infection
9%
Intestine Flora
9%
Skin Injury
7%
Alpha Smooth Muscle Actin
7%
Pseudomonas aeruginosa
7%
Fourier Transform Infrared Spectroscopy
7%
Alpha Actin
7%
Contractile Protein
7%
Infectious Agent
7%